Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Lutz Büllesfeld"'
Publikováno v:
Aktuelle Kardiologie. 11:565-569
ZusammenfassungDie orale Antikoagulation ist der Standard zur Prävention von Embolien bei Patienten mit Vorhofflimmern. Der interventionelle Vorhofohrverschluss ist eine Alternative zur oralen Antikoagulation bei Patienten mit Vorhofflimmern und Kon
Autor:
Mohammad Kassar, Sonja Widmer, Nicolas Brugger, Stephan Windecker, Lukas Hunziker, Thomas Pilgrim, Christoph Gräni, Mirjam Winkel, Lutz Büllesfeld, George C.M. Siontis, Fabien Praz, Noé Corpataux, Taishi Okuno
Publikováno v:
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventionsREFERENCES. 98(7)
OBJECTIVES To investigate whether the integrative echocardiographic criteria used in the cardiovascular outcomes assessment of the mitraclip percutaneous therapy (COAPT) for heart failure patients with functional mitral regurgitation study predict ou
Autor:
Stephan Windecker, Neil Fam, Jeremy Edwards, Aris Moschovitis, Robert Moss, Florian Deuschl, Michael Chrissoheris, Fabien Praz, Konstantinos Spargias, Robert Schueler, Ulrich Schäfer, Saibal Kar, John G. Webb, Georg Nickenig, Lutz Büllesfeld, Robert H. Boone, Moody Makar, Ted Feldman
Publikováno v:
The Lancet. 390:773-780
Summary Background Severe mitral regurgitation is associated with impaired prognosis if left untreated. Using the devices currently available, transcatheter mitral valve repair (TMVr) remains challenging in complex anatomical situations. We report th
Autor:
George C.M. Siontis, Stefan Stortecky, Lutz Büllesfeld, Stephan Windecker, Peter Wenaweser, Peter Jüni, Thomas Pilgrim, Bernhard Meier
Publikováno v:
Journal of the American College of Cardiology. 64(2):129-140
Background Atrioventricular (AV) conduction disturbances requiring permanent pacemaker (PPM) implantation may complicate transcatheter aortic valve replacement (TAVR). Available evidence on predictors of PPM is sparse and derived from small studies.
Autor:
Lutz Büllesfeld, Eberhard Grube
Publikováno v:
Journal of Interventional Cardiology. 15:471-475
Local delivery of immunosuppressive or antiproliferative agents using a drug-eluting stent is a new technology that is supposed to inhibit in-stent restenosis, thus providing a biological and mechanical solution. This technique is a very promising. T
Publikováno v:
Herz. 27:508-513
Trotz verbesserter Techniken ist die Entwicklung einer Restenose im Laufe der Zeit weiterhin das Hauptproblem katheterinterventioneller Therapien der koronaren Herzerkrankung. Ein neues Therapiekonzept zur Vermeidung der postinterventionellen Resteno
Autor:
Giulio G. Stefanini, Peter Wenaweser, Dik Heg, Peter Jüni, Aris Moschovitis, Thomas Pilgrim, Stephan Windecker, Thomas Zanchin, Bindu Kalesan, Crochan J. O'Sullivan, Masanori Taniwaki, Bernhard Meier, Ahmed A. Khattab, Lorenz Räber, Lutz Büllesfeld
Publikováno v:
O'Sullivan, Crochan John; Stefanini, Giulio; Räber, Lorenz; Heg, Dik; Taniwaki, Masanori; Kalesan, Bindu; Pilgrim, Thomas; Zanchin, Thomas; Moschovitis, Aris; Büllesfeld, Lutz; Khattab, Ahmed Aziz; Meier, Bernhard; Wenaweser, Peter Martin; Jüni, Peter; Windecker, Stephan (2014). Impact of stent overlap on long-term clinical outcomes in patients treated with newer-generation drug-eluting stents. EuroIntervention, 9(9), pp. 1076-1084. Europa Digital & Publishing 10.4244/EIJV9I9A182
Aims: Early-generation drug-eluting stent (DES) overlap (OL) is associated with impaired long-term clinical outcomes whereas the impact of OL with newer-generation DES is unknown. Our aim was to assess the impact of OL on long-term clinical outcomes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0796f9a35e75fcb15dd99a01cdcf45da
Autor:
Crochan O'Sullivan, Giulio Stefanini, Lorenz Räber, Dik Heg, Masanori Taniwaki, Bindu Kalesan, Thomas Pilgrim, Thomas Zanchin, Aris Moschovitis, Lutz Büllesfeld, Ahmed Khattab, Peter Wenaweser, Bernhard Meier, Peter Juni, Stephan Windecker
Publikováno v:
Journal of the American College of Cardiology. 60(17)
Autor:
Ênio E, Guérios, Steffen, Gloekler, Thomas, Pilgrim, Stefan, Stortecky, Lutz, Büllesfeld, Ahmed A, Khattab, Christoph, Huber, Bernhard, Meier, Stephan, Windecker, Peter, Wenaweser
Publikováno v:
The Journal of invasive cardiology. 24(9)
Unfavorable immediate or delayed results after transcatheter aortic valve implantation (TAVI) may be a consequence of bioprosthesis malfunctioning, malpositioning, embolization, or degeneration. Deployment of a second valve within the first one impla
Autor:
Alexander Kadner, Balthasar Eberle, Stephan Windecker, Peter Wenaweser, Bernhard Meier, Gabor Erdös, Nadja Roth, Bindu Kalesan, Lutz Büllesfeld, Thierry Carrel, Ahmed A. Khattab, Stefan Stortecky, Peter Jüni, Fabienne Meuli, Christoph Huber, Thomas Pilgrim
Publikováno v:
American heart journal. 161(6)
Background Transcatheter aortic valve implantation (TAVI) is a treatment option for high-risk patients with severe aortic stenosis. Previous reports focused on a single device or access site, whereas little is known of the combined use of different d